Nazarbayev University in Kazakhstan has initiated a bold plan to build the nation’s most advanced oncology treatment and research center to serve the Eurasian region. With more than 30,000 new cases of cancer diagnosed annually in Kazakhstan — and more than half at a late stage — this initiative is vital.
Nazarbayev University in Kazakhstan selected UPMC to conduct a feasibility study and outline plans for developing a national oncology treatment and research center.
Under a consultative agreement, UPMC assessed the types of cancer services needed in Kazakhstan and the viability of a national oncology center in the capital city of Astana.
Nazarbayev University will manage the government-funded National Research Oncology Center, which is expected to include:
The agreement underscores the excellent reputation that UPMC clinicians and staff have earned worldwide for offering high-quality cancer care through an extensive network of sites, providing easy access for patients.
Kazakhstan's oncology center will incorporate processes used by UPMC in successfully integrating care, research, and medical education at more than 35 UPMC Hillman Cancer Center locations in the United States, Ireland, and Italy.
The model will produce: